DK0973790T3 - Estra-5(10),7-diener med østrogen aktivitet - Google Patents

Estra-5(10),7-diener med østrogen aktivitet

Info

Publication number
DK0973790T3
DK0973790T3 DK98915224T DK98915224T DK0973790T3 DK 0973790 T3 DK0973790 T3 DK 0973790T3 DK 98915224 T DK98915224 T DK 98915224T DK 98915224 T DK98915224 T DK 98915224T DK 0973790 T3 DK0973790 T3 DK 0973790T3
Authority
DK
Denmark
Prior art keywords
estra
dienes
estrogenic activity
estrogenic
activity
Prior art date
Application number
DK98915224T
Other languages
English (en)
Inventor
Leonard Alexander Mcdonald
Michael Z Kagan
Syed Muzafar Shah
Panolil Raveendranath
Mark Andrew Collins
Fangming Kong
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0973790T3 publication Critical patent/DK0973790T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98915224T 1997-04-07 1998-04-02 Estra-5(10),7-diener med østrogen aktivitet DK0973790T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83533697A 1997-04-07 1997-04-07
US85057097A 1997-05-02 1997-05-02
PCT/US1998/006461 WO1998045315A1 (en) 1997-04-07 1998-04-02 Estra-5(10),7-dienes with estrogenic activity

Publications (1)

Publication Number Publication Date
DK0973790T3 true DK0973790T3 (da) 2003-09-22

Family

ID=27125779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915224T DK0973790T3 (da) 1997-04-07 1998-04-02 Estra-5(10),7-diener med østrogen aktivitet

Country Status (15)

Country Link
EP (1) EP0973790B1 (da)
JP (1) JP2001518896A (da)
KR (1) KR20010006118A (da)
CN (1) CN1259137A (da)
AR (1) AR012341A1 (da)
AT (1) ATE242263T1 (da)
AU (1) AU738486B2 (da)
BR (1) BR9809748A (da)
CA (1) CA2286457A1 (da)
DE (1) DE69815329T2 (da)
DK (1) DK0973790T3 (da)
ES (1) ES2200334T3 (da)
NZ (1) NZ500217A (da)
PT (1) PT973790E (da)
WO (1) WO1998045315A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200301023A1 (ru) * 2001-03-16 2004-02-26 Уайт Заместительная терапия эстрогенами
WO2009120678A2 (en) * 2008-03-24 2009-10-01 Signa Chemistry, Llc Birch reduction of steroid substrates via alkali metal-silica gel materials
AU2013289344A1 (en) 2012-07-10 2015-02-05 Bayer Pharma Aktiengesellschaft 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MA38349A1 (fr) 2013-02-21 2017-02-28 Bayer Pharma AG Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1093360B (de) * 1958-02-17 1960-11-24 Ayerst Mckenna & Harrison Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe
US2930805A (en) * 1959-01-19 1960-03-29 American Home Prod Novel derivatives of estrane
US3340278A (en) * 1965-05-03 1967-09-05 American Home Prod 5(10), 7-estradiene-3, 17-dione and the process for the production thereof
DK0565296T3 (da) * 1992-04-07 1996-12-09 Neurim Pharma 1991 Anvendelse af melatonin til fremstilling af et lægemiddel til behandling af godartet prostatahyperplasi

Also Published As

Publication number Publication date
BR9809748A (pt) 2000-06-20
CA2286457A1 (en) 1998-10-15
ES2200334T3 (es) 2004-03-01
NZ500217A (en) 2001-11-30
DE69815329D1 (de) 2003-07-10
DE69815329T2 (de) 2004-04-29
EP0973790B1 (en) 2003-06-04
AR012341A1 (es) 2000-10-18
CN1259137A (zh) 2000-07-05
PT973790E (pt) 2003-10-31
ATE242263T1 (de) 2003-06-15
JP2001518896A (ja) 2001-10-16
WO1998045315A1 (en) 1998-10-15
EP0973790A1 (en) 2000-01-26
KR20010006118A (ko) 2001-01-26
AU6946298A (en) 1998-10-30
AU738486B2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
DE69723886D1 (de) Dünne,komfortable,interlabiale absorbierende struktur
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
NL300416I1 (nl) Estrogene middelen
NO971814L (no) Östrogene midler
FI953523L (fi) Fenyyli-3-dimetyyliamino-propaaniyhdisteet, joilla on farmakologista vaikutusta
DE69805643D1 (de) Membrane-elektroden-anordnung
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DE69618624D1 (de) Inhaliervorrichtung
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
FI960529L (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents (b,f)oksepiinit
FR2720813B1 (fr) Support de structure.
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
PT973790E (pt) Estra-5, 7-dienos com actividade estrogenica
DE69829900D1 (de) Neigungsverstellvorrichtung
DE59508591D1 (de) 2-arylcyclopentan-1,3-dion-derivate
HK1024923A (en) Estra-5(10), 7-dienes with estrogenic activity
IT1268116B1 (it) Sedia.
FI963155A0 (fi) Diconelaserreaktor, Arringsstaelle med tryckturbin, Diconefusionsaccelerator (dubbelkon)
IT235750Y1 (it) Sci.
ES1029350Y (es) Nueva estructura de asiento.
FI971570A0 (fi) Styrsystem foer foerbraenningsluften i en ackumulerande, vedeldad eldstad
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FI945785A0 (fi) Pimpelspoe, fiskeredokap
ES1039107Y (es) Seccionador perfeccionado.